FDA Drug recall D-0852-2026
Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited
- FDA Drug
- Class II
- ongoing
- Published 2026-09-23
On 2026-09-23 the FDA classified a Class II recall of Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited by Inventia Healthcare, citing failed Dissolution Specifications.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0852-2026 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2026-09-03 |
| Published | 2026-09-23 |
| Last updated | 2026-09-29 05:30 UTC |
| Company | Inventia Healthcare |
| Distribution | US |
Product
Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01
Reason
Failed Dissolution Specifications
Identifiers
| ndc | 64980-599-01 |
|---|---|
| ndc | 64980-599-10 |
| ndc | 64980-600-01 |
| code_info | Batch # RISA24002; Exp Date: 04/2027 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-29 05:30 UTC. Current status: ongoing.
Other recalls by Inventia Healthcare
- Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: Inventia Healthcare Limited, Additional Ambe…
FDA Drug · Class II · 2026-06-24 · Inventia Healthcare
All Inventia Healthcare recalls
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0852-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.